EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C45H69N5O8S |
| Net Charge | 0 |
| Average Mass | 840.141 |
| Monoisotopic Mass | 839.48669 |
| SMILES | [H]N1C(=O)/C(C)=C/[C@H]2CSC(=N2)[C@@H](C)[C@@H](O)C[C@H](C)C[C@@H](C(C)(C)C)OC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H]1Cc1ccc(OC)cc1 |
| InChI | InChI=1S/C45H69N5O8S/c1-13-27(3)38-43(55)50-20-14-15-35(50)44(56)58-37(45(7,8)9)22-26(2)21-36(51)29(5)40-46-32(25-59-40)23-28(4)39(52)47-34(24-31-16-18-33(57-12)19-17-31)42(54)48(10)30(6)41(53)49(38)11/h16-19,23,26-27,29-30,32,34-38,51H,13-15,20-22,24-25H2,1-12H3,(H,47,52)/b28-23+/t26-,27-,29-,30-,32-,34-,35-,36-,37-,38-/m0/s1 |
| InChIKey | KXUJXPZXILTXDA-CKIYSKEDSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Lyngbya majuscula (ncbitaxon:158786) | - | PubMed (11389621) | |
| Lyngbya bouillonii (ncbitaxon:207920) | - | PubMed (18461997) | Strain: PS372 |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| apratoxin A (CHEBI:35212) has role antineoplastic agent (CHEBI:35610) |
| apratoxin A (CHEBI:35212) has role metabolite (CHEBI:25212) |
| apratoxin A (CHEBI:35212) is a 1,3-thiazoles (CHEBI:38418) |
| apratoxin A (CHEBI:35212) is a apratoxin (CHEBI:35214) |
| IUPAC Name |
|---|
| 7'''.1,4-anhydro(N-{3-[2-(3,7-dihydroxy-5,8,8-trimethylnonan-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-2-methylpropenoyl}-O-methyl-L-tyrosyl-N-methyl-L-alanyl-N-methyl-L-isoleucyl-L-proline) |
| Synonyms | Source |
|---|---|
| apratoxin A | ChemIDplus |
| (2S,3S,5S,7S,10S,16S,19S,22S,25E,27S)-16-[(2S)-butan-2-yl]-7-tert-butyl-3-hydroxy-22-(4-methoxybenzyl)-2,5,17,19,20,25-hexamethyl-8-oxa-29-thia-14,17,20,23,30-pentaazatricyclo[25.2.1.010,14]triaconta-1(30),25-diene-9,15,18,21,24-pentone | IUPAC |
| N-((2E)-3-((4S)-4,5-dihydro-2-((1S,2S,4S,6S)-2,6-dihydroxy-1,4,7,7-tetramethyloctyl)-4-thiazolyl)-2-methyl-1-oxo-2-propenyl)-O-methyl-L-tyrosyl-N-methyl-L-alanyl-N-methyl-L-isoleucyl-L-proline-(4-1(6))-lactone | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| Apratoxin_A | Wikipedia |
| US2011294720 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:9181215 | Reaxys |
| CAS:350791-64-9 | ChemIDplus |
| Citations |
|---|